Organization Overview
Alternative names
abiraterone (zytiga) (1 trial)
acetylsalicylic acid (aspirin) (7 trials)
adefovir dipivoxil (hepsera) (5 trials)
allopurinol (zyloprim) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (5 trials)
arsenic trioxide (trisenox) (3 trials)
atorvastatin (lipitor) (4 trials)
bicalutamide (casodex) (5 trials)
bortezomib (velcade) (5 trials)
budesonide (rhinocort) (1 trial)
carboplatin (paraplatin) (56 trials)
celecoxib (celebrex) (7 trials)
cenegermin-bkbj (oxervate) (2 trials)
cisatracurium (nimbex) (1 trial)
cisplatin (platinol) (133 trials)
clopidogrel (plavix) (1 trial)
cyclophosphamide (cytoxan) (58 trials)
cytarabine (cytosar-u) (10 trials)
dapagliflozin (farxiga) (2 trials)
desmopressin (ddavp) (2 trials)
dexmedetomidine (precedex) (10 trials)
esketamine (spravato) (1 trial)
esomeprazole (nexium) (4 trials)
estradiol (progynon depot) (3 trials)
etanercept (enbrel) (6 trials)
etoposide (vepesid) (22 trials)
fluorometholone (fml) (1 trial)
formoterol (foradil) (1 trial)
goserelin (zoladex) (3 trials)
hepatitis b immune globulin (human) (BayHep B) (1 trial)
infliximab (remicade) (5 trials)
insulin aspart (novolog) (1 trial)
insulin glargine (toujeo) (3 trials)
insulin human (humulin) (12 trials)
insulin lispro (humalog) (4 trials)
interferon alpha-2b (Intron-A) (19 trials)
iodixanol (visipaque) (1 trial)
lamivudine (epivir) (7 trials)
levobupivacaine (chirocaine) (1 trial)
lidocaine (xylocaine) (1 trial)
linagliptin (tradjenta) (2 trials)
luspatercept (Reblozyl) (1 trial)
mercaptopurine (purinethol) (4 trials)
metformin (glucophage) (5 trials)
mitoxantrone (novantrone) (7 trials)
montelukast (singulair) (3 trials)
mycophenolate (myfortic) (9 trials)
olaparib (lynparza) (3 trials)
pioglitazone (actos) (3 trials)
pitavastatin (livalo) (1 trial)
prednisone (meticorten) (23 trials)
propofol (diprivan) (9 trials)
ranibizumab (lucentis) (7 trials)
rasburicase (elitek) (1 trial)
realgar-indigo naturalis (1 trial)
remifentanil (ultiva) (4 trials)
rituximab (rituxan) (19 trials)
rivaroxaban (xarelto) (1 trial)
ruxolitinib (jakafi) (1 trial)
saxagliptin (onglyza) (2 trials)
sevoflurane (ultane) (5 trials)
sitagliptin (januvia) (9 trials)
somatropin (protropin) (6 trials)
sorafenib (nexavar) (22 trials)
sulfasalazine (azulfidine) (2 trials)
tacrolimus (prograf) (12 trials)
tamoxifen (nolvadex) (10 trials)
telbivudine (tyzeka) (6 trials)
tenofovir (viread) (11 trials)
thalidomide (Thalomid) (9 trials)
thymalfasin (zadaxin) (4 trials)
vancomycin (Vancocin) (1 trial)
vecuronium (norcuron) (1 trial)
vedolizumab (entyvio) (1 trial)
adalimumab (humira) (3 trials)
alemtuzumab (campath) (1 trial)
allogeneic blood cells (3 trials)
allogeneic bone marrow derived mesenchymal stem cell (1 trial)
alprostadil (prostin) (2 trials)
autologous mesenchymal stem cells (15 trials)
azacitidine (vidaza) (4 trials)
azathioprine (imuran) (7 trials)
bevacizumab (avastin) (38 trials)
bleomycin (blenoxane) (3 trials)
busulfan (myleran) (15 trials)
capecitabine (xeloda) (61 trials)
cd25 monoclonal antibody (1 trial)
cetuximab (erbitux) (10 trials)
cladribine (leustatin) (4 trials)
cord blood hematopoietic stem cell (1 trial)
crizotinib (xalkori) (1 trial)
cyclosporine (sandimmune) (10 trials)
cytokine induced killer cells (4 trials)
decitabine (dacogen) (9 trials)
docetaxel (taxotere) (66 trials)
doxorubicin (Doxil) (31 trials)
doxycycline (vibramycin) (5 trials)
dydrogesterone (gynorest) (2 trials)
epirubicin (ellence) (12 trials)
erlotinib (tarceva) (10 trials)
filgrastim (neupogen) (13 trials)
fludarabine (fludara) (11 trials)
fluorouracil (efudex) (98 trials)
fulvestrant (faslodex) (8 trials)
gemcitabine (gemzar) (62 trials)
icosapent ethyl (vascepa) (1 trial)
idarubicin (idamycin) (3 trials)
irinotecan (Camptosar) (32 trials)
lenvatinib (lenvima) (25 trials)
levoleucovorin (fusilev) (1 trial)
megakaryocytic progenitor cells (1 trial)
melphalan (alkeran) (4 trials)
methylprednisolone (medrol) (10 trials)
mitomycin (mutamycin) (3 trials)
monosialoganglioside (1 trial)
monosialotetrahexosyl ganglioside (4 trials)
moxifloxacin (avelox) (4 trials)
nitric oxide (inomax) (1 trial)
olanzapine (zyprexa) (2 trials)
oprelvekin (Neumega) (2 trials)
osimertinib (tagrisso) (7 trials)
oxaliplatin (eloxatin) (98 trials)
paclitaxel (taxol) (82 trials)
palonosetron (aloxi) (3 trials)
pegaspargase (oncaspar) (12 trials)
pemetrexed (alimta) (25 trials)
pertuzumab (perjeta) (5 trials)
progesterone (progestasert) (4 trials)
propranolol (inderal) (1 trial)
recombinant human adenovirus type 5 (1 trial)
recombinant human choriogonadotropin alfa (Ovidrel) (3 trials)
Recombinant Human Type-5 Adenovirus (1 trial)
sacubitril (Entresto) (1 trial)
sargramostim (leukine) (4 trials)
silver diammine fluoride (1 trial)
sirolimus (rapamune) (1 trial)
temozolomide (temodar) (10 trials)
topotecan (hycamtin) (2 trials)
toremifene (fareston) (2 trials)
trastuzumab (herceptin) (15 trials)
tripterygium wilfordii (1 trial)
triptorelin (Trelstar) (1 trial)
umbilical cord mesenchymal stem cells (12 trials)
ursodeoxycholic acid (1 trial)
ursodeoxycholyltaurine (1 trial)
venetoclax (venclexta) (3 trials)
vinorelbine (navelbine) (14 trials)
1,4-butanethiosulfonate (1 trial)
ademetionine1,4-butanethiosulfonate (1 trial)
albumin (Human) (Plasbumin) (1 trial)
allogeneic adipose derived mesenchymal stem cell (2 trials)
allogeneic cord blood (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (5 trials)
allogeneic lymphocytes (1 trial)
allogeneic stem cells (1 trial)
anastrozole (arimidex) (1 trial)
asparaginase (elspar) (3 trials)
autologous cik cells (1 trial)
autologous cytokine induced killer cells (1 trial)
autologous dendritic cells (1 trial)
autologous tumor infiltrating lymphocytes (3 trials)
azithromycin (zithromax) (1 trial)
bacillus mesentericus jpc (1 trial)
basiliximab (simulect) (1 trial)
bifidobacterium bifidum (1 trial)
binimetinib (mektovi) (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
bromocriptine (parlodel) (2 trials)
cd44v6-specific car gene-engineered t cells (1 trial)
clarithromycin (biaxin) (2 trials)
clostridium butyricum (1 trial)
cyanocobalamin (berocca) (3 trials)
daunorubicin (cerubidine) (1 trial)
deferoxamine (desferal) (1 trial)
dendritic cell activated cytokine-induced killer cell (1 trial)
desloratadine (clarinex) (1 trial)
durvalumab (imfinzi) (2 trials)
edaravone (radicava) (3 trials)
encorafenib (braftovi) (2 trials)
everolimus (zortress) (2 trials)
exemestane (aromasin) (2 trials)
genetically engineered ny-eso-1-specific t lymphocytes (2 trials)
gentamicin (garamycin) (1 trial)
granisetron (kytril) (1 trial)
human placental derived stem cells (1 trial)
ibrutinib (imbruvica) (1 trial)
interferon alpha-2a (roferon-a) (7 trials)
itraconazole (sporanox) (1 trial)
lanreotide (somatuline depot) (1 trial)
lenalidomide (revlimid) (6 trials)
levofloxacin (levaquin) (1 trial)
masct:multiple antigens specific cellular therapy (1 trial)
minocycline (minocin) (3 trials)
mirtazapine (remeron) (1 trial)
multiple sarcoma-specific car-t cells (1 trial)
multiple signals loaded dendritic cells vaccine (1 trial)
neratinib maleate (nerlynx) (1 trial)
palbociclib (ibrance) (2 trials)
pembrolizumab (keytruda) (5 trials)
pomalidomide (pomalyst) (1 trial)
potassium chloride (klor-con) (1 trial)
prednisolone (hydeltra) (1 trial)
procaine merethoxylline (1 trial)
regorafenib (stivarga) (3 trials)
scopolamine (transderm scop) (1 trial)
streptococcus faecalis jpc (1 trial)
trolamine polypeptide oleate condensate (cerumenex) (1 trial)
tumour infiltrating lymphocytes (2 trials)
umbilical mesenchymal stem cells derived exosomes (1 trial)
vemurafenib (zelboraf) (1 trial)
acetaminophen (tylenol) (1 trial)
aldesleukin (proleukin) (2 trials)
allogeneic natural killer cells (1 trial)
chimeric antigen receptor t cells, eps8 or wt1 peptide specific dendritic cell (1 trial)
crispr/cas9 plasmid, c32-447 (1 trial)
cxcr5 modified egfr chimeric antigen receptor autologous t cells (1 trial)
daclatasvir (daklinza) (2 trials)
dendritic cells loaded with 17 antigens (1 trial)
endostatin adenovirus (1 trial)
hiv-specific cd8 cells (1 trial)
indocyanine green (ic-green) (3 trials)
lmp2 antigen-specific tcr t cells (1 trial)
amantadine (symmetrel) (1 trial)
artemisiacapillaris thunb (1 trial)
benazepril (lotensin) (1 trial)
brimonidine (alphagan) (1 trial)
brinzolamide (azopt) (1 trial)
carboprost tromethamine (hemabate) (1 trial)
carboxypolymethylene (1 trial)
ciltacabtagene autoleucel (Carvykti) (1 trial)
ciprofloxacin (cipro) (1 trial)
clindamycin (cleocin) (1 trial)
dehydroepiandrosterone (1 trial)
desflurane (suprane) (1 trial)
diclofenac (voltaren) (1 trial)
dipyridamole (persantine) (1 trial)
ethambutol (myambutol) (1 trial)
flurbiprofen (ansaid) (2 trials)
ganciclovir (cytovene) (1 trial)
gardenia jasminoides ellis (1 trial)
gatifloxacin (Zymar) (1 trial)
isoniazid (nydrazid) (1 trial)
lactobacillus paracasei (2 trials)
latanoprost (xalatan) (1 trial)
menopausal gonadotropin (1 trial)
metronidazole (flagyl) (3 trials)
nalbuphine (nubain) (2 trials)
norepinephrine (levophed) (2 trials)
omega-3 fatty acids (omacor) (1 trial)
oxycodone (oxycontin) (1 trial)
oxytocin (syntocinon) (1 trial)
peginterferon beta-1a (Plegridy) (1 trial)
pilocarpine (ocusert) (1 trial)
platelet rich plasma (1 trial)
proparacaine (ophthaine) (3 trials)
pyrazinamide (Aldinamide) (1 trial)